BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ritz A, Kolorz J, Hubertus J, Ley-Zaporozhan J, von Schweinitz D, Koletzko S, Häberle B, Schmid I, Kappler R, Berger M, Lurz E. Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma. Pediatr Blood Cancer 2021;68:e28862. [PMID: 33438330 DOI: 10.1002/pbc.28862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Romano A, Triarico S, Rinninella E, Natale L, Brizi MG, Cintoni M, Raoul P, Maurizi P, Attinà G, Mastrangelo S, Gasbarrini A, Mele MC, Ruggiero A. Clinical Impact of Nutritional Status and Sarcopenia in Pediatric Patients with Bone and Soft Tissue Sarcomas: A Pilot Retrospective Study (SarcoPed). Nutrients 2022;14:383. [PMID: 35057564 DOI: 10.3390/nu14020383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Triarico S, Rinninella E, Mele MC, Cintoni M, Attinà G, Ruggiero A. Prognostic impact of sarcopenia in children with cancer: a focus on the psoas muscle area (PMA) imaging in the clinical practice. Eur J Clin Nutr 2021. [PMID: 34621000 DOI: 10.1038/s41430-021-01016-y] [Reference Citation Analysis]
3 Ritz A, Froeba-Pohl A, Kolorz J, Vigodski V, Hubertus J, Ley-Zaporozhan J, von Schweinitz D, Häberle B, Schmid I, Kappler R, Lurz E, Berger M. Total Psoas Muscle Area as a Marker for Sarcopenia Is Related to Outcome in Children With Neuroblastoma. Front Surg 2021;8:718184. [PMID: 34490339 DOI: 10.3389/fsurg.2021.718184] [Reference Citation Analysis]